FDA Enjoins Pharmas From Selling Unapproved Drugs

Law360, New York (April 13, 2009, 12:00 AM EDT) -- The U.S. Food and Drug Administration has won a permanent injunction barring two pharmaceutical companies and their owners from manufacturing and selling unapproved drugs, after the companies and the administration agreed on a settlement.

The FDA announced Friday that Neilgen Pharmaceuticals Inc. and parent company Advent Pharmaceuticals Inc. signed off on a consent decree that will halt the companies' manufacture of drugs that have not been approved by the administration. The decree entered into force Thursday after being signed by Judge Benson Legg of the U.S....
To view the full article, register now.